The FY2025 (Dec) proxy of Agenus names 19 peer companies for pay. Among Agenus and these peers, CEO pay was the lowest of 4 and total shareholder return was the lowest of 4.
4th highest of 4in Agenus and its pay peers, FY2025 (Dec) by CEO pay:
$1.4M$5.4M
4th highest of 4in Agenus and its pay peers, FY2025 (Dec) by total shareholder return:
$7$64
Pay peer group, FY2025 (Dec) proxy
| Precigen | ||
| Voyager Therapeutics | ||
| Fate Therapeutics | ||
| 2seventy bio | Not disclosed | Not disclosed |
| ALX Oncology | Not disclosed | Not disclosed |
| Atara Biotherapeutics, Inc. | Not disclosed | Not disclosed |
| Immuneering | Not disclosed | Not disclosed |
| Inhibrx | Not disclosed | Not disclosed |
| Inovio Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Instil Bio | Not disclosed | Not disclosed |
| Karyopharm Therapeutics Inc. | Not disclosed | Not disclosed |
| MacroGenics, Inc. | Not disclosed | Not disclosed |
| Mersana Therapeutics, Inc. | Not disclosed | Not disclosed |
| Precision BioSciences, Inc. | Not disclosed | Not disclosed |
| Repare Therapeutics | Not disclosed | Not disclosed |
| Seres Therapeutics, Inc. | Not disclosed | Not disclosed |
| Sutro Biopharma | Not disclosed | Not disclosed |
| Zentalis Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| iTeos Therapeutics | Not disclosed | Not disclosed |
19 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.